Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

By T. Patel. Hepatology, 2001

1,024 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/313180153ba6e8ff8ee7394e59b184d484a27d7e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. H. B. EL‐SERAG
2. J. Llovet
3. G. Gores

In Pulmonary and Respiratory Medicine

1. G. Gores
2. H. B. EL‐SERAG

In Surgery

1. G. Gores
2. H. B. EL‐SERAG
3. J. Llovet

Citations in the corpus

• Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? (2004, background): “Previous studies have reported that the incidence of ICC started to increase after 1985 [7]; therefore, we examined the secular trends in the proportion of patients with microscopic confirmation and with staged disease throughout the study period as well as in a separate analysis restricted to the p”
• Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise (2016, background): “During the past 15 years, many studies have raised the concern that the incidence of andmortality related to ICC are on the rise worldwide, whereas the incidence of ECC has remained relatively stableover time[1–8].”
• Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions (2017, background): “Resection is the recommended curative treatment but because the disease is usually diagnosed in advanced state, only 10%–20% of diagnosed patients are surgical candidates [215].”
• Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. (2014, result): “An increase in mortality rates from iCCA was concomitantly reported in studies from the US and the UK [12,13].”